Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

CAPS Rating: 3 out of 5

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.

Recs

0
Player Avatar rannici (< 20) Submitted: 10/27/2011 9:24:45 AM : Outperform Start Price: $67.84 ALXN Score: +31.78

just following the trend...

Report this Post Reply

Featured Broker Partners


Advertisement